Stobadine protects ion pump ATPases from free radical inhibition.
Clinch
K A
KA
Department of Pharmacology, School of Medicine, University of Washington, Seattle 98195.
Vincenzi
F F
FF
Rohn
T T
TT
Hinds
T R
TR
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000975:Antioxidants / Q000494:pharmacology*; D002084:Butylated Hydroxytoluene / Q000494:pharmacology; D000252:Calcium-Transporting ATPases / Q000037:antagonists & inhibitors / Q000378:metabolism; D002243:Carbolines / Q000494:pharmacology*; D004492:Edetic Acid / Q000494:pharmacology; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000201:enzymology; D005609:Free Radicals; D006801:Humans; D066298:In Vitro Techniques; D007501:Iron / Q000494:pharmacology; D007502:Iron Chelating Agents / Q000494:pharmacology; D015227:Lipid Peroxidation / Q000187:drug effects; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors / Q000378:metabolism; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism
D000975:Antioxidants; D002243:Carbolines; D005609:Free Radicals; D007502:Iron Chelating Agents; D017392:Thiobarbituric Acid Reactive Substances; D002084:Butylated Hydroxytoluene; D004492:Edetic Acid; D007501:Iron; D000251:Adenosine Triphosphatases; D000252:Calcium-Transporting ATPases; D000254:Sodium-Potassium-Exchanging ATPase; C100106:dicarbine